IP Library Granted Patent US 10,542,918
Granted Patent B2
US 10,542,918 · App. 14/061,251 · Granted Jan 28, 2020

Modulation of a response signal to distinguish between analyte and background signals

Inventors: Andrew Conrad (Mountain View, CA); Eric Peeters (Mountain View, CA); Vikram Singh Bajaj (Mountain View, CA); Jason Thompson (Mountain View, CA); Mark Askew (Mountain View, CA)
Assignee: Verily Life Sciences LLC
A61B5/14546A61B5/05A61B5/681A61B5/742
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,542,918
App. No.
14/061,251
Granted
Jan 28, 2020
Kind
B2
Abstract

A method for modulating a response signal includes introducing functionalized particles into a lumen of subsurface vasculature, wherein the functionalized particles are configured to interact with one or more target analytes present in blood circulating in the subsurface vasculature; and non-invasively detecting the one or more target analytes. A response signal, which may include a background signal and an analyte response signal related to interaction of the functionalized particles with the one or more target analytes, is transmitted from the subsurface vasculature. A modulation configured to alter the response signal such that the analyte response signal is affected differently than the background signal may be applied to a portion of subsurface vasculature. Analyte detection may be achieved by differentiating the analyte response signal from the background signal.

Claims (46)

1. A method, comprising:

detecting an analyte response signal transmitted from within a lumen of subsurface vasculature inside a body, wherein the analyte response signal is indicative of interaction of functionalized particles with one or more target analytes present in blood circulating in the subsurface vasculature, wherein the functionalized particles each comprise an antibody covalently attached to a nanoparticle;

detecting an unbound particle signal transmitted from within the lumen of subsurface vasculature, wherein the unbound particle signal is indicative of functionalized particles that are not interacting with the one or more target analytes;

detecting a background signal;

applying a modulation to a portion of the subsurface vasculature, wherein the modulation alters the analyte response signal and the unbound particle signal, such that the analyte response signal is affected differently than the unbound particle signal and the background signal; and

differentiating the analyte response signal from the unbound particle signal and the background signal based, at least in part, on the modulation.

2. The method of claim 1 , further comprising introducing the functionalized particles into the lumen of subsurface vasculature by injection, ingestion, inhalation, or transdermally.

3. The method of claim 1 , further comprising:

directing an interrogating signal into the subsurface vasculature; and

detecting the analyte response signal transmitted from the subsurface vasculature in response to the interrogating signal.

4. The method of claim 1 , wherein the modulation alters the analyte response signal by spatially modulating the functionalized particles that are interacting with the one or more target analytes.

5. The method of claim 1 , wherein the modulation alters one or more properties of the functionalized particles that are interacting with the one or more target analytes.

6. The method of claim 5 , wherein the one or more properties of the functionalized particles comprises one or more of: optical properties, magnetic properties, electric properties, thermal properties, acoustic properties, and physical properties.

7. A method, comprising:

detecting an analyte response signal transmitted from an environment, wherein the analyte response signal is indicative of interaction of functionalized particles with one or more target analytes, wherein the functionalized particles each comprise an antibody covalently attached to a nanoparticle;

detecting an unbound particle signal transmitted from the environment, wherein the unbound particle signal is indicative of functionalized particles that are not interacting with the one or more target analytes;

detecting a background signal;

applying a modulation to a portion of the environment, wherein the modulation alters the analyte response signal and unbound particle signal, such that the analyte response signal is affected differently than the unbound particle signal and background signal; and

differentiating the analyte response signal from the unbound particle signal and the background signal based, at least in part, on the modulation.

8. The method of claim 7 , further comprising:

directing an interrogating signal into the environment; and

detecting the analyte response signal transmitted from the environment in response to the interrogating signal.

9. The method of claim 7 , wherein the environment comprises a fluid conduit.

10. The method of claim 7 , wherein the environment comprises a fluid reservoir.

11. The method of claim 7 , wherein the environment comprises a living body.

12. The method of claim 11 , wherein the functionalized particles interact with one or more target analytes present in the living body.

13. The method of claim 11 , wherein the functionalized particles are embedded in skin or tissue of the living body.

14. The method of claim 13 , wherein the functionalized particles interact with one or more target analytes present in the skin or tissue of the living body.

15. The method of claim 11 , wherein the functionalized particles are introduced into a body fluid comprising blood, tear fluid, urine, lymph, cerebrospinal fluid, or mucus.

16. The method of claim 15 , wherein the functionalized particles interact with one or more target analytes present in the body fluid.

17. A device, comprising:

a detector that detects:

an analyte response signal transmitted from an environment, wherein the analyte response signal is indicative of interaction of one or more target analytes with functionalized particles present in the environment, wherein the functionalized particles each comprise an antibody covalently attached to a nanoparticle;

an unbound particle signal transmitted from the environment, wherein the unbound particle signal is indicative of functionalized particles that are not interacting with the one or more target analytes; and

a background signal;

a modulation source that alters the analyte response signal and the unbound particle signal, such that the analyte response signal is affected differently than the unbound particle signal and background signal; and

a processor that non-invasively detects the one or more target analytes by differentiating the analyte response signal from the unbound particle signal and the background signal based, at least in part, on the modulation.

18. The device of claim 17 , further comprising a wearable device mountable to an external surface of the environment, wherein the detector is mounted on the wearable device.

19. The device of claim 18 , wherein at least a portion of the modulation source is mounted on said wearable device.

20. The device of claim 17 , wherein said modulation source alters the analyte response signal differently than the background signal.

21. The device of claim 17 , further comprising an interrogating signal source that directs an interrogation signal source into the environment, the analyte response signal being transmitted in response to the interrogating signal.

22. The device of claim 17 , wherein the environment comprises a fluid conduit.

23. The device of claim 17 , wherein the environment comprises a fluid reservoir.

24. The device of claim 17 , wherein the environment comprises a living body.

25. The method of claim 11 , further comprising:

introducing the functionalized particles into the living body by injection, ingestion, inhalation, or transdermally.

Assignments (4)
CHANGE OF ADDRESS Recorded Nov 19, 2024
From: VERILY LIFE SCIENCES LLC
To: VERILY LIFE SCIENCES LLC
Reel/Frame 069390/0656 →
CHANGE OF NAME Recorded Dec 17, 2015
From: GOOGLE LIFE SCIENCES LLC
To: VERILY LIFE SCIENCES LLC
Reel/Frame 037317/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2015
From: GOOGLE INC.
To: GOOGLE LIFE SCIENCES LLC
Reel/Frame 037288/0768 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2013
From: CONRAD, ANDREW; PEETERS, ERIC; BAJAJ, VIKRAM SINGH; THOMPSON, JASON; ASKEW, MARK
To: GOOGLE INC.
Reel/Frame 031473/0776 →
Continuity (1)
Related Publication 20150110721A1 · Apr 23, 2015
Cited By (1)
US 12,605,108